Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Stem Cell Reports|December 4, 2018
Transcription Factor Levels after Forward Programming of Human Pluripotent Stem Cells with GATA1, FLI1, and TAL1 Determine Megakaryocyte versus Erythroid Cell Fate DecisionAmanda Dalby, Jose Ballester-Beltrán, Chiara Lincetto, et al.
Science Advances|March 22, 2023
Functional neurological restoration of amputated peripheral nerve using biohybrid regenerative bioelectronicsAmy E Rochford, Alejandro Carnicer-Lombarte, Malak Kawan, et al.
Science Advances|February 16, 2022
Mapping the biogenesis of forward programmed megakaryocytes from induced pluripotent stem cellsMoyra Lawrence, Arash Shahsavari, Susanne Bornelöv, et al.
Blood Advances|April 12, 2021
Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactorsAmanda L Evans, Amanda Dalby, Holly R Foster, et al.
Biomaterials|August 18, 2018
Structurally graduated collagen scaffolds applied to the ex vivo generation of platelets from human pluripotent stem cell-derived megakaryocytes: Enhancing production and purityJennifer H Shepherd, Daniel Howard, Amie K Waller, et al.
The Journal of Clinical Endocrinology and Metabolism|August 18, 2021
Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger AdultsMarc Diedisheim, Etienne Dancoisne, Jean-François Gautier, et al.
Haematologica|March 12, 2026
Thyroid hormones induce an acute platelet release mechanism via integrin αVβ3Holly R Foster, Nina Herbert, Christian A Di Buduo, et al.
Nature Communications|July 29, 2017
Corrigendum: Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programmingThomas Moreau, Amanda L Evans, Louella Vasquez, et al.
Nature Communications|April 8, 2016
Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programmingThomas Moreau, Amanda L Evans, Louella Vasquez, et al.
Cancers|October 13, 2021
Clinical Characteristics, Care Trajectories and Mortality Rate of SARS-CoV-2 Infected Cancer Patients: A Multicenter Cohort StudyMarc-Antoine Benderra, Ainhoa Aparicio, Judith Leblanc, et al.
Pageof 4